Fluidic Precision: Exploring a CAGR of 11.1% in the Microfluidics Market by 2031 | FMI

Liquids can flow through a number of tiny channels or mediums, such nozzles, pumps, or chips, thanks to the science of Microfluidics Market. These technologies can be used to create products that can direct and regulate fluids at scales as small as tens to hundreds of micrometres.

Microfluidics enables the simultaneous execution of many experiments. Throughput can be increased in places where good spatiotemporal control is possible. Thus, less expensive and valuable chemicals, fluids, and biological tests are employed, resulting in lower costs. Microfluidics-based technologies are used in a wide range of applications, such as clinical diagnostics, analytical testing, point-of-care testing, and medication delivery. In analytical testing for genomics, proteomics, and cell-based studies, microfluidics-based instruments and chips are employed.

Microfluidics systems provide benefits including straightforward automation, less sample and reagent usage overall, and quicker analysis times. For a range of testing, such as chemical and biological research, this makes it a desirable option. The system also permits parallel assay execution, which reduces assay expenses and execution time.

𝐆𝐞𝐭 𝐑𝐞𝐜𝐞𝐧𝐭𝐥𝐲 𝐔𝐩𝐝𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 𝐨𝐟 𝐌𝐚𝐫𝐤𝐞𝐭 𝐚𝐬 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲! https://www.futuremarketinsights.com/reports/sample/rep-gb-398

Through 2031, the microfluidics market is anticipated to grow at a CAGR of 11.1%. By 2031, the market is projected to reach a value of US$ 17.8 billion, according to Future Market Insights. In 2022, the market was estimated to be worth US$ 6.8 billion.

Microfluidic technology has recently advanced 3D cell culture, allowing for the creation of microenvironments that encourage tissue differentiation and can even mimic the interface between two tissues. Spatiotemporal chemical gradients and the mechanical microenvironment of living organs can both benefit from it. The need for microfluidic lab-on-chip technology is rising in the healthcare and pharmaceutical industries as well as in applications for counterterrorism, the environment, food safety, and the military.

Additionally, miniaturised biosensors' speed, portability, accessibility, and affordability as well as the growing consumer, environmental, and security sectors have significant commercial potential.

The development of novel microfluidic platforms for drug discovery, portable diagnostics, and other applications drives the microfluidics market. Players with a substantial product portfolio, patented technology used in clinical research and in-vitro diagnostics applications, and nearby GMP-certified manufacturing facilities dominate the collaboration area.

In order to overcome difficulties associated with the fabrication included into the microfluidics devices, many companies are substituting the mixers in these devices with the bubbles at large. This can be the opportunity to improve the efficiency of the microfluidics devices creating a huge opportunity in the market.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐌𝐢𝐜𝐫𝐨𝐟𝐥𝐮𝐢𝐝𝐢𝐜𝐬 𝐒𝐭𝐮𝐝𝐲:

• The ceramics segment is anticipated to hold the maximum share of 39.9% in 2022, expanding at 13.0% CAGR during the forecast period. Ceramics' superior chemical resistivity, flexibility, and strength make them ideal for producing microfluidics devices, as seen by their significant market share.

• The point of care testing segment is projected to account for 32.6% of the total market share in 2022 by application. In the fields of genomics and proteomics, point-of-care testing devices offer a lot of potential. These devices, for example, aid in the identification of the DNA of bacteria that cause various diseases and are also employed in protein analysis.

• In-vitro diagnostics and life science research together hold over 53% of the market in 2022 and this trend is expected to continue during the forecast period as well. The growing number of experiment carried out in life science research using microfluidics is rising. This is propelling the sector forward. Aside from that, with increasing diseases, is increasing the in-vitro diagnostics demand.

• North America is expected to account for about 25.4% of the global microfluidics market. The high frequency and growth in incidence of various diseases, and government funding for the research and clinical testing by various institutions in the North America will assist market expansion.

𝐄𝐦𝐛𝐫𝐚𝐜𝐞 𝐒𝐦𝐚𝐫𝐭𝐞𝐫 𝐂𝐡𝐨𝐢𝐜𝐞𝐬 𝐖𝐢𝐭𝐡 𝐎𝐮𝐫 𝐌𝐞𝐭𝐡𝐨𝐝𝐨𝐥𝐨𝐠𝐲-𝐃𝐞𝐫𝐢𝐯𝐞𝐝 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐓𝐨𝐝𝐚𝐲! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-398

𝐖𝐡𝐨 𝐢𝐬 𝐰𝐢𝐧𝐧𝐢𝐧𝐠?

The key market players covered by FMI include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad Laboratories, Inc., Qiagen NV, SCHOTT AG and thinXXS Microtechnology.

Some of the leading manufacturers of the microfluidics market are focusing on the development of advanced and cost-effective products and undertaking acquisitions to increase global presence.

• In October 2021, Thermo Fisher Scientific Charts Digital PCR expansion after Combinati acquisition.

• In November 2019, MicroMedicine, Inc., launched the Sorterra Cell Isolation System, an automated, microfluidics-based cell isolation technology at the Society for Immunotherapy of Cancer (SITC) Meeting.

𝐖𝐚𝐧𝐭 𝐦𝐨𝐫𝐞 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global microfluidics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on microfluidics market segment based on material (polymer {polyvinyl chloride (PVC) non-polyvinyl chloride}, glass, silicon, metal and ceramics), application (point of care testing, clinical diagnostics, drug delivery and analytical testing {genomics, proteomics, cell based analysis and others}), and industry (pharmaceuticals, in-vitro diagnostics, environmental research, life science research, clinical diagnostics) across seven major regions.

𝐌𝐢𝐜𝐫𝐨𝐟𝐥𝐮𝐢𝐝𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐂𝐚𝐭𝐞𝐠𝐨𝐫𝐲:

𝐁𝐲 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥:

• Polymer
o Polyvinyl Chloride (PVC)
o Non-polyvinyl Chloride
• Glass
• Silicon
• Metal
• Ceramics

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧:

• Point of care testing
• Clinical Diagnostics
• Drug Delivery
• Analytical Testing
o Genomics
o Proteomics
o Cell based Analysis
o Others

𝐁𝐲 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

• Pharmaceuticals
• In-vitro Diagnostics
• Environmental Research
• Life Science Research
• Clinical Diagnostics

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈'𝐬 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐨𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧

At Home Heart Health Testing Market:
https://www.futuremarketinsights.com/reports/at-home-heart-health-testing-market

Breast Fillers Market: https://www.futuremarketinsights.com/reports/breast-fillers-market

Digital Breast Tomosynthesis (DBT) Equipment Market: https://www.futuremarketinsights.com/reports/digital-breast-tomosynthesis-dbt-system-market

𝐀𝐛𝐨𝐮𝐭 𝐅𝐮𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 (𝐅𝐌𝐈)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
𝐅𝐨𝐫 𝐒𝐚𝐥𝐞𝐬 𝐄𝐧𝐪𝐮𝐢𝐫𝐢𝐞𝐬:sales@futuremarketinsights.com
𝐖𝐞𝐛𝐬𝐢𝐭𝐞: https://www.futuremarketinsights.com
𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.futuremarketinsights.com/reports/microfluidics-market

This release was published on openPR.